Target intelligence / Profile preview

RN7SK pseudogene 239 (RN7SKP239)

Target: RN7SKP239
Molecular classification: Other (Pseudogene)

Overview

RN7SK pseudogene 239 (RN7SKP239) is a processed pseudogene located on chromosome 11 (chr11:67362414-67362708, human genome hg38)[2][5]. Pseudogenes are DNA sequences similar to known genes but are generally nonfunctional and do not produce active RNA or protein products. While the parental gene RN7SK encodes a small nuclear RNA involved in transcriptional regulation and ribonucleoprotein complexes[1][3][6], the pseudogene RN7SKP239 does not have a demonstrated role in cellular processes or disease, nor does it interact with therapeutics or serve as a biomarker. It is listed in gene databases for completeness but is not considered a druggable or functional target[5][2].

Other names: RN7SKP239RNA, 7SK small nuclear pseudogene 239

Beyond the preview

Go deeper on RN7SK pseudogene 239 (RN7SKP239).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RN7SK pseudogene 239 (RN7SKP239).

Explore the full profile